Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 25, 2025

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

479

[Therapeutic advances for indolent lymphomas].

M Ogura

    Nihon Rinsho. Japanese Journal of Clinical Medicine
    |March 31, 2000
    PubMed
    Summary

    New treatments are needed for indolent lymphomas due to repeated relapses. Novel agents like rituximab and stem cell transplantation show promise for improving outcomes in follicular lymphoma.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Semiquantitative CLDN18 expression and clinical outcomes in patients with CLDN18-positive gastric cancer treated with zolbetuximab plus chemotherapy.

    ESMO gastrointestinal oncology·2026
    Same author

    BevRam-GC01 study protocol: a phase I trial of bevacizumab plus ramucirumab and paclitaxel in advanced gastric cancer.

    ESMO gastrointestinal oncology·2026
    Same author

    The clinical utility of an mGPS and SII combined score in patients with advanced gastric cancer treated with nivolumab monotherapy.

    ESMO gastrointestinal oncology·2026
    Same author

    Real-world clinical impact of first-line immune checkpoint inhibitor-based therapy in advanced esophageal squamous cell carcinoma.

    ESMO gastrointestinal oncology·2026
    Same author

    Clinical efficacy of nivolumab-based therapy for HER2-negative diffuse-type advanced gastric or gastroesophageal junction adenocarcinoma with peritoneal dissemination.

    ESMO gastrointestinal oncology·2026
    Same author

    Managing zolbetuximab-induced nausea and vomiting: a proposal for a pragmatic approach in clinical practice.

    ESMO gastrointestinal oncology·2026

    Area of Science:

    • Oncology
    • Hematology

    Context:

    • Indolent lymphomas, such as follicular lymphoma, often present with a relapsed or advanced stage.
    • Standard chemotherapy yields high initial response rates but is followed by frequent relapses, leading to a median survival of approximately 6.2 years.

    Purpose:

    • To review novel therapeutic agents and strategies for indolent lymphomas.
    • To evaluate the effectiveness of emerging treatments in patients with relapsed or advanced disease.

    Summary:

    • High-dose chemoradiotherapy with autologous hematopoietic stem cell transplantation is a highly effective strategy.
    • Promising results are reported for chimeric anti-CD20 monoclonal antibody (rituximab), radioimmunotherapy, interferon, and allogeneic mini-transplantation.
    • Recent therapeutic approaches for MALT lymphoma and mantle cell lymphoma are also discussed.

    Impact:

    • These novel strategies offer potential for improved patient outcomes and survival in indolent lymphomas.
    • The review highlights the need for evaluating new agents to overcome treatment resistance and prolong remission durations.

    More Related Videos

    Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
    08:31

    Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

    Published on: September 12, 2025

    686
    Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
    08:17

    Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

    Published on: October 30, 2016

    21.8K

    Related Experiment Videos

    Last Updated: Dec 25, 2025

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
    08:31

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

    Published on: October 17, 2025

    479
    Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
    08:31

    Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

    Published on: September 12, 2025

    686
    Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
    08:17

    Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

    Published on: October 30, 2016

    21.8K